Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Forus, an AI healthcare platform, just raised $150 million in a Series C round, tripling its valuation to $3 billion in just four months. The platform uses AI agents to help doctors and patients navigate the gap between a prescription and actually starting treatment — covering insurance approvals, financial assistance, and drug supply. With over $300 million raised in total, Forus is now eyeing expansion across more specialties and care settings.
Forus, an AI-powered healthcare platform formerly known as Tandem, has closed a $150 million Series C funding round led by Bain Capital Ventures, pushing its valuation to $3 billion — a threefold jump in just four months. Existing backers including Thrive Capital, General Catalyst, and Accel also participated, bringing the company's total funding to over $300 million.
The New York-based startup's platform deploys AI agents to smooth out the notoriously frustrating journey between a doctor writing a prescription and a patient actually receiving their medication. That means handling insurance prior authorizations, financial assistance programs, and medicine supply logistics — all in one place. The company plans to use the new funds to expand across more medical specialties and care settings, broaden its technology's capabilities, and grow its workforce.
By the Numbers:
Why it matters: The prescription-to-treatment gap is a major source of patient drop-off and delayed care. Forus is betting that AI can fix the administrative bottleneck — and investors are clearly buying in.
